ZOETIS INC (ZTS) Fundamental Analysis & Valuation

NYSE:ZTS • US98978V1035

122.36 USD
+0.93 (+0.77%)
At close: Mar 9, 2026
122.36 USD
0 (0%)
After Hours: 3/9/2026, 5:05:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ZTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall ZTS gets a fundamental rating of 7 out of 10. We evaluated ZTS against 193 industry peers in the Pharmaceuticals industry. ZTS scores excellent on profitability, but there are some minor concerns on its financial health. ZTS is not valued too expensively and it also shows a decent growth rate. Finally ZTS also has an excellent dividend rating. These ratings could make ZTS a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

9

1. ZTS Profitability Analysis

1.1 Basic Checks

  • ZTS had positive earnings in the past year.
  • ZTS had a positive operating cash flow in the past year.
  • Each year in the past 5 years ZTS has been profitable.
  • In the past 5 years ZTS always reported a positive cash flow from operatings.
ZTS Yearly Net Income VS EBIT VS OCF VS FCFZTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of ZTS (17.28%) is better than 95.85% of its industry peers.
  • Looking at the Return On Equity, with a value of 80.25%, ZTS belongs to the top of the industry, outperforming 99.48% of the companies in the same industry.
  • ZTS's Return On Invested Capital of 21.95% is amongst the best of the industry. ZTS outperforms 97.41% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZTS is significantly above the industry average of 13.08%.
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROIC 21.95%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ZTS Yearly ROA, ROE, ROICZTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 28.23%, ZTS belongs to the best of the industry, outperforming 93.78% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ZTS has grown nicely.
  • ZTS has a better Operating Margin (38.54%) than 96.89% of its industry peers.
  • ZTS's Operating Margin has improved in the last couple of years.
  • ZTS has a Gross Margin of 71.89%. This is in the better half of the industry: ZTS outperforms 78.24% of its industry peers.
  • ZTS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
ZTS Yearly Profit, Operating, Gross MarginsZTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ZTS Health Analysis

2.1 Basic Checks

  • ZTS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for ZTS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ZTS has less shares outstanding
  • ZTS has a worse debt/assets ratio than last year.
ZTS Yearly Shares OutstandingZTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ZTS Yearly Total Debt VS Total AssetsZTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ZTS has an Altman-Z score of 5.52. This indicates that ZTS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.52, ZTS is in the better half of the industry, outperforming 76.68% of the companies in the same industry.
  • ZTS has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as ZTS would need 3.96 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.96, ZTS belongs to the top of the industry, outperforming 87.05% of the companies in the same industry.
  • ZTS has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
  • ZTS has a worse Debt to Equity ratio (2.71) than 79.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Altman-Z 5.52
ROIC/WACC2.43
WACC9.03%
ZTS Yearly LT Debt VS Equity VS FCFZTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • ZTS has a Current Ratio of 3.03. This indicates that ZTS is financially healthy and has no problem in meeting its short term obligations.
  • ZTS has a Current ratio (3.03) which is in line with its industry peers.
  • A Quick Ratio of 1.94 indicates that ZTS should not have too much problems paying its short term obligations.
  • ZTS has a Quick ratio (1.94) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.94
ZTS Yearly Current Assets VS Current LiabilitesZTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ZTS Growth Analysis

3.1 Past

  • ZTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
  • The Earnings Per Share has been growing by 10.77% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 2.28% in the past year.
  • The Revenue has been growing slightly by 7.24% on average over the past years.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%

3.2 Future

  • Based on estimates for the next years, ZTS will show a small growth in Earnings Per Share. The EPS will grow by 7.80% on average per year.
  • The Revenue is expected to grow by 5.30% on average over the next years.
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue Next Year4.92%
Revenue Next 2Y4.86%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZTS Yearly Revenue VS EstimatesZTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ZTS Yearly EPS VS EstimatesZTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. ZTS Valuation Analysis

4.1 Price/Earnings Ratio

  • ZTS is valuated rather expensively with a Price/Earnings ratio of 19.06.
  • 83.94% of the companies in the same industry are more expensive than ZTS, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ZTS to the average of the S&P500 Index (26.29), we can say ZTS is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 17.29, ZTS is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 82.38% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ZTS to the average of the S&P500 Index (24.60), we can say ZTS is valued slightly cheaper.
Industry RankSector Rank
PE 19.06
Fwd PE 17.29
ZTS Price Earnings VS Forward Price EarningsZTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 83.42% of the companies in the same industry are more expensive than ZTS, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ZTS is valued cheaper than 84.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.62
EV/EBITDA 14.02
ZTS Per share dataZTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZTS does not grow enough to justify the current Price/Earnings ratio.
  • ZTS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)1.77
EPS Next 2Y8.92%
EPS Next 3Y8.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ZTS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.64%, ZTS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.70, ZTS pays a better dividend. On top of this ZTS pays more dividend than 91.19% of the companies listed in the same industry.
  • ZTS's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • On average, the dividend of ZTS grows each year by 20.56%, which is quite nice.
  • ZTS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ZTS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)20.56%
Div Incr Years11
Div Non Decr Years11
ZTS Yearly Dividends per shareZTS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 33.26% of the earnings are spent on dividend by ZTS. This is a low number and sustainable payout ratio.
  • ZTS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
ZTS Yearly Income VS Free CF VS DividendZTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ZTS Dividend Payout.ZTS Dividend Payout, showing the Payout Ratio.ZTS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ZTS Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

NYSE:ZTS (3/9/2026, 5:05:00 PM)

After market: 122.36 0 (0%)

122.36

+0.93 (+0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners100.79%
Inst Owner Change4.39%
Ins Owners0.07%
Ins Owner Change3.93%
Market Cap51.65B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts77.6
Price Target155.47 (27.06%)
Short Float %3.71%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.04
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years11
Div Non Decr Years11
Ex-Date04-20
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-2.51%
PT rev (3m)-8.55%
EPS NQ rev (1m)2.55%
EPS NQ rev (3m)2.87%
EPS NY rev (1m)3.06%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 19.06
Fwd PE 17.29
P/S 5.46
P/FCF 22.62
P/OCF 17.79
P/B 15.51
P/tB N/A
EV/EBITDA 14.02
EPS(TTM)6.42
EY5.25%
EPS(NY)7.08
Fwd EY5.78%
FCF(TTM)5.41
FCFY4.42%
OCF(TTM)6.88
OCFY5.62%
SpS22.43
BVpS7.89
TBVpS-1.03
PEG (NY)1.86
PEG (5Y)1.77
Graham Number33.76
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROCE 27.58%
ROIC 21.95%
ROICexc 26.6%
ROICexgc 40.59%
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
FCFM 24.12%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Debt/EBITDA 2.19
Cap/Depr 127.52%
Cap/Sales 6.56%
Interest Coverage 13.98
Cash Conversion 70.21%
Profit Quality 85.41%
Current Ratio 3.03
Quick Ratio 1.94
Altman-Z 5.52
F-Score6
WACC9.03%
ROIC/WACC2.43
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.92%
Revenue Next 2Y4.86%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.93%
EBIT Next 3Y9.75%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%

ZOETIS INC / ZTS FAQ

What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?

ChartMill assigns a fundamental rating of 7 / 10 to ZTS.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.


How profitable is ZOETIS INC (ZTS) stock?

ZOETIS INC (ZTS) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for ZTS stock?

The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 10.25% in the next year.


Is the dividend of ZOETIS INC sustainable?

The dividend rating of ZOETIS INC (ZTS) is 7 / 10 and the dividend payout ratio is 33.26%.